From Equity Insight stocks to watch !!
Sona Nanotech (CSE: SONA) (OTCQB: SNANF) is a Corona virus stock which we put on high alert as one of our top covid-19 stocks back in march at around $.51cents, and since then, shares of SONA have rocketed to a high of $3.80 for a return of 645%. Shares of SONA rallied to a high of $3.80 on rumors that the company had received validation of the company’s Covid-19 test kit and is preparing for mass manufacturing. On May 22nd 2020 announce that it has engaged MRIGlobal, a leading scientific research organization to assist SONA in conduct clinical validation studies and analytics for its Covid-19 rapid testing kits. These studies will be used for a submission to Health Canada for regulatory approval and Emergency Use Authorization (EUA) with the Food and Drug Administration (FDA). CEO of SONA Darren Rowles was quoted "We are delighted to be moving into the final validation process and looking forward to the potential of a test that can tangibly advance the safety and quality of life for our communities. Our lab team, in particular, deserves credit for their tremendous work in significantly progressing our antigen test prototype in a short period of time”. We remain bullish on SONA as one of the few small cap Covid stocks and investors should continue to keep a close eye as positive developments from Health Canada and the FDA could propel shares of SONA significantly higher.
Final validation process in order to file submission to HC for EUA !!